3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms
1
Multiple Myeloma
1
Medulloblastoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
pembrolizumab
4
Platinum
4
Cisplatin
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Radiotherapy, Intensity-Modulated
3
Cetuximab
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
cemiplimab
2
Radiotherapy
2
Radiation
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
merphos
1
durvalumab
1
cabozantinib
1
atezolizumab
1
X-Rays
1
Transurethral Resection of Bladder
1
Taxes
1
Radiosurgery
1
Paclitaxel
1
Nivolumab
1
Methotrexate
1
Interviews as Topic
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
Vemurafenib
×
30 days
×
Clear all
No trials found.